APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antivenom

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.

Selected research

Market Analysis & Forecast

Global Antivenom Market Analysis and Forecast 2026-2032

26 December 2025193 pages

Choose your research edition.

Industry ResearchAntivenom Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Antivenom Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Antivenom Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antivenom Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Antivenom Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.

CSL is the world leading manufacturer in global Anti-Venom market with the market share of 27%, in terms of revenue, followed by Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech and MicroPharm. These 11 companies accounted for 68% of the revenue market share in 2019. Asia-Pacific, Middle East and Africa are the largest consumption regions, occupied about 77% of market share, in terms of volume. The application of Anti-Venom in hospital and clinics take the main global shares. The polyvalent Anti-Venom takes more global revenue shares compared to the Monovalent Anti-Venom, which accounts for 67% in 2019.

This report presents an overview of global market for Antivenom, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Antivenom, also provides the sales of main regions and countries. Of the upcoming market potential for Antivenom, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antivenom sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Antivenom market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Antivenom sales, projected growth trends, production technology, application and end-user industry.

Antivenom Segment by Company

CSL

Merck

BTG

Pfizer

Haffkine Bio-Pharmaceutical

Rare Disease Therapeutics

Flynn Pharma

Vins Bioproducts

Bharat Serums and Vaccines

Serum Biotech

MicroPharm

Antivenom Segment by Type

Polyvalent antivenom

Monovalent antivenom

Antivenom Segment by Application

Non-profit Institutions

Hospitals and Clinic

Antivenom Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antivenom market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antivenom and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antivenom.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Antivenom in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Antivenom manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antivenom sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Antivenom Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Polyvalent antivenom Major Manufacturers Table 3. Monovalent antivenom Major Manufacturers Table 4. Global Antivenom Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Non-profit Institutions Major Manufacturers Table 6. Hospitals and Clinic Major Manufacturers Table 7. Antivenom Industry Trends Table 8. Antivenom Industry Drivers Table 9. Antivenom Industry Opportunities and Challenges Table 10. Antivenom Industry Restraints Table 11. Global Antivenom Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Antivenom Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Antivenom Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Antivenom Revenue Market Share by Region (2021-2026) Table 15. Global Antivenom Revenue Market Share by Region (2027-2032) Table 16. Global Antivenom Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Vials) Table 17. Global Antivenom Sales by Region (2021-2026) & (K Vials) Table 18. Global Antivenom Sales by Region (2027-2032) & (K Vials) Table 19. Global Antivenom Sales Market Share by Region (2021-2026) Table 20. Global Antivenom Sales Market Share by Region (2027-2032) Table 21. Global Antivenom Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Antivenom Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Antivenom Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Antivenom Sales Market Share by Manufacturers (2021-2026) Table 25. Global Antivenom Sales Price (USD/Vial) of Manufacturers (2021-2026) Table 26. Global Antivenom Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Antivenom Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Antivenom Manufacturers, Product Type & Application Table 29. Global Antivenom Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Antivenom by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Antivenom Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Antivenom Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Antivenom Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Antivenom Revenue Market Share by Type (2021-2026) Table 36. Global Antivenom Revenue Market Share by Type (2027-2032) Table 37. Global Antivenom Sales by Type 2021 VS 2025 VS 2032 (K Vials) Table 38. Global Antivenom Sales by Type (2021-2026) & (K Vials) Table 39. Global Antivenom Sales by Type (2027-2032) & (K Vials) Table 40. Global Antivenom Sales Market Share by Type (2021-2026) Table 41. Global Antivenom Sales Market Share by Type (2027-2032) Table 42. Global Antivenom Price by Type (2021-2026) & (USD/Vial) Table 43. Global Antivenom Price by Type (2027-2032) & (USD/Vial) Table 44. Global Antivenom Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Antivenom Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Antivenom Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Antivenom Revenue Market Share by Application (2021-2026) Table 48. Global Antivenom Revenue Market Share by Application (2027-2032) Table 49. Global Antivenom Sales by Application 2021 VS 2025 VS 2032 (K Vials) Table 50. Global Antivenom Sales by Application (2021-2026) & (K Vials) Table 51. Global Antivenom Sales by Application (2027-2032) & (K Vials) Table 52. Global Antivenom Sales Market Share by Application (2021-2026) Table 53. Global Antivenom Sales Market Share by Application (2027-2032) Table 54. Global Antivenom Price by Application (2021-2026) & (USD/Vial) Table 55. Global Antivenom Price by Application (2027-2032) & (USD/Vial) Table 56. CSL Company Information Table 57. CSL Business Overview Table 58. CSL Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 59. CSL Antivenom Product Portfolio Table 60. CSL Recent Development Table 61. Merck Company Information Table 62. Merck Business Overview Table 63. Merck Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 64. Merck Antivenom Product Portfolio Table 65. Merck Recent Development Table 66. BTG Company Information Table 67. BTG Business Overview Table 68. BTG Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 69. BTG Antivenom Product Portfolio Table 70. BTG Recent Development Table 71. Pfizer Company Information Table 72. Pfizer Business Overview Table 73. Pfizer Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 74. Pfizer Antivenom Product Portfolio Table 75. Pfizer Recent Development Table 76. Haffkine Bio-Pharmaceutical Company Information Table 77. Haffkine Bio-Pharmaceutical Business Overview Table 78. Haffkine Bio-Pharmaceutical Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 79. Haffkine Bio-Pharmaceutical Antivenom Product Portfolio Table 80. Haffkine Bio-Pharmaceutical Recent Development Table 81. Rare Disease Therapeutics Company Information Table 82. Rare Disease Therapeutics Business Overview Table 83. Rare Disease Therapeutics Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 84. Rare Disease Therapeutics Antivenom Product Portfolio Table 85. Rare Disease Therapeutics Recent Development Table 86. Flynn Pharma Company Information Table 87. Flynn Pharma Business Overview Table 88. Flynn Pharma Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 89. Flynn Pharma Antivenom Product Portfolio Table 90. Flynn Pharma Recent Development Table 91. Vins Bioproducts Company Information Table 92. Vins Bioproducts Business Overview Table 93. Vins Bioproducts Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 94. Vins Bioproducts Antivenom Product Portfolio Table 95. Vins Bioproducts Recent Development Table 96. Bharat Serums and Vaccines Company Information Table 97. Bharat Serums and Vaccines Business Overview Table 98. Bharat Serums and Vaccines Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 99. Bharat Serums and Vaccines Antivenom Product Portfolio Table 100. Bharat Serums and Vaccines Recent Development Table 101. Serum Biotech Company Information Table 102. Serum Biotech Business Overview Table 103. Serum Biotech Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 104. Serum Biotech Antivenom Product Portfolio Table 105. Serum Biotech Recent Development Table 106. MicroPharm Company Information Table 107. MicroPharm Business Overview Table 108. MicroPharm Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 109. MicroPharm Antivenom Product Portfolio Table 110. MicroPharm Recent Development Table 111. North America Antivenom Revenue by Type (2021-2026) & (US$ Million) Table 112. North America Antivenom Revenue by Type (2027-2032) & (US$ Million) Table 113. North America Antivenom Sales by Type (2021-2026) & (K Vials) Table 114. North America Antivenom Sales by Type (2027-2032) & (K Vials) Table 115. North America Antivenom Sales Price by Type (2021-2026) & (USD/Vial) Table 116. North America Antivenom Sales Price by Type (2027-2032) & (USD/Vial) Table 117. North America Antivenom Revenue by Application (2021-2026) & (US$ Million) Table 118. North America Antivenom Revenue by Application (2027-2032) & (US$ Million) Table 119. North America Antivenom Sales by Application (2021-2026) & (K Vials) Table 120. North America Antivenom Sales by Application (2027-2032) & (K Vials) Table 121. North America Antivenom Sales Price by Application (2021-2026) & (USD/Vial) Table 122. North America Antivenom Sales Price by Application (2027-2032) & (USD/Vial) Table 123. North America Antivenom Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. North America Antivenom Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 125. North America Antivenom Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 126. North America Antivenom Sales by Country (2021 VS 2025 VS 2032) & (K Vials) Table 127. North America Antivenom Sales by Country (2021-2026) & (K Vials) Table 128. North America Antivenom Sales by Country (2027-2032) & (K Vials) Table 129. North America Antivenom Sales Price by Country (2021-2026) & (USD/Vial) Table 130. North America Antivenom Sales Price by Country (2027-2032) & (USD/Vial) Table 131. United States Antivenom Revenue (2021-2032) & (US$ Million) Table 132. Canada Antivenom Revenue (2021-2032) & (US$ Million) Table 133. Mexico Antivenom Revenue (2021-2032) & (US$ Million) Table 134. Europe Antivenom Revenue by Type (2021-2026) & (US$ Million) Table 135. Europe Antivenom Revenue by Type (2027-2032) & (US$ Million) Table 136. Europe Antivenom Sales by Type (2021-2026) & (K Vials) Table 137. Europe Antivenom Sales by Type (2027-2032) & (K Vials) Table 138. Europe Antivenom Sales Price by Type (2021-2026) & (USD/Vial) Table 139. Europe Antivenom Sales Price by Type (2027-2032) & (USD/Vial) Table 140. Europe Antivenom Revenue by Application (2021-2026) & (US$ Million) Table 141. Europe Antivenom Revenue by Application (2027-2032) & (US$ Million) Table 142. Europe Antivenom Sales by Application (2021-2026) & (K Vials) Table 143. Europe Antivenom Sales by Application (2027-2032) & (K Vials) Table 144. Europe Antivenom Sales Price by Application (2021-2026) & (USD/Vial) Table 145. Europe Antivenom Sales Price by Application (2027-2032) & (USD/Vial) Table 146. Europe Antivenom Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Europe Antivenom Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 148. Europe Antivenom Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 149. Europe Antivenom Sales by Country (2021 VS 2025 VS 2032) & (K Vials) Table 150. Europe Antivenom Sales by Country (2021-2026) & (K Vials) Table 151. Europe Antivenom Sales by Country (2027-2032) & (K Vials) Table 152. Europe Antivenom Sales Price by Country (2021-2026) & (USD/Vial) Table 153. Europe Antivenom Sales Price by Country (2027-2032) & (USD/Vial) Table 154. Germany Antivenom Revenue (2021-2032) & (US$ Million) Table 155. France Antivenom Revenue (2021-2032) & (US$ Million) Table 156. U.K. Antivenom Revenue (2021-2032) & (US$ Million) Table 157. Italy Antivenom Revenue (2021-2032) & (US$ Million) Table 158. Russia Antivenom Revenue (2021-2032) & (US$ Million) Table 159. Spain Antivenom Revenue (2021-2032) & (US$ Million) Table 160. Netherlands Antivenom Revenue (2021-2032) & (US$ Million) Table 161. Switzerland Antivenom Revenue (2021-2032) & (US$ Million) Table 162. Sweden Antivenom Revenue (2021-2032) & (US$ Million) Table 163. Poland Antivenom Revenue (2021-2032) & (US$ Million) Table 164. China Antivenom Revenue by Type (2021-2026) & (US$ Million) Table 165. China Antivenom Revenue by Type (2027-2032) & (US$ Million) Table 166. China Antivenom Sales by Type (2021-2026) & (K Vials) Table 167. China Antivenom Sales by Type (2027-2032) & (K Vials) Table 168. China Antivenom Sales Price by Type (2021-2026) & (USD/Vial) Table 169. China Antivenom Sales Price by Type (2027-2032) & (USD/Vial) Table 170. China Antivenom Revenue by Application (2021-2026) & (US$ Million) Table 171. China Antivenom Revenue by Application (2027-2032) & (US$ Million) Table 172. China Antivenom Sales by Application (2021-2026) & (K Vials) Table 173. China Antivenom Sales by Application (2027-2032) & (K Vials) Table 174. China Antivenom Sales Price by Application (2021-2026) & (USD/Vial) Table 175. China Antivenom Sales Price by Application (2027-2032) & (USD/Vial) Table 176. Asia Antivenom Revenue by Type (2021-2026) & (US$ Million) Table 177. Asia Antivenom Revenue by Type (2027-2032) & (US$ Million) Table 178. Asia Antivenom Sales by Type (2021-2026) & (K Vials) Table 179. Asia Antivenom Sales by Type (2027-2032) & (K Vials) Table 180. Asia Antivenom Sales Price by Type (2021-2026) & (USD/Vial) Table 181. Asia Antivenom Sales Price by Type (2027-2032) & (USD/Vial) Table 182. Asia Antivenom Revenue by Application (2021-2026) & (US$ Million) Table 183. Asia Antivenom Revenue by Application (2027-2032) & (US$ Million) Table 184. Asia Antivenom Sales by Application (2021-2026) & (K Vials) Table 185. Asia Antivenom Sales by Application (2027-2032) & (K Vials) Table 186. Asia Antivenom Sales Price by Application (2021-2026) & (USD/Vial) Table 187. Asia Antivenom Sales Price by Application (2027-2032) & (USD/Vial) Table 188. Asia Antivenom Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 189. Asia Antivenom Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 190. Asia Antivenom Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 191. Asia Antivenom Sales by Country (2021 VS 2025 VS 2032) & (K Vials) Table 192. Asia Antivenom Sales by Country (2021-2026) & (K Vials) Table 193. Asia Antivenom Sales by Country (2027-2032) & (K Vials) Table 194. Asia Antivenom Sales Price by Country (2021-2026) & (USD/Vial) Table 195. Asia Antivenom Sales Price by Country (2027-2032) & (USD/Vial) Table 196. Japan Antivenom Revenue (2021-2032) & (US$ Million) Table 197. South Korea Antivenom Revenue (2021-2032) & (US$ Million) Table 198. India Antivenom Revenue (2021-2032) & (US$ Million) Table 199. Australia Antivenom Revenue (2021-2032) & (US$ Million) Table 200. Taiwan Antivenom Revenue (2021-2032) & (US$ Million) Table 201. Southeast Asia Antivenom Revenue (2021-2032) & (US$ Million) Table 202. SAMEA Antivenom Revenue by Type (2021-2026) & (US$ Million) Table 203. SAMEA Antivenom Revenue by Type (2027-2032) & (US$ Million) Table 204. SAMEA Antivenom Sales by Type (2021-2026) & (K Vials) Table 205. SAMEA Antivenom Sales by Type (2027-2032) & (K Vials) Table 206. SAMEA Antivenom Sales Price by Type (2021-2026) & (USD/Vial) Table 207. SAMEA Antivenom Sales Price by Type (2027-2032) & (USD/Vial) Table 208. SAMEA Antivenom Revenue by Application (2021-2026) & (US$ Million) Table 209. SAMEA Antivenom Revenue by Application (2027-2032) & (US$ Million) Table 210. SAMEA Antivenom Sales by Application (2021-2026) & (K Vials) Table 211. SAMEA Antivenom Sales by Application (2027-2032) & (K Vials) Table 212. SAMEA Antivenom Sales Price by Application (2021-2026) & (USD/Vial) Table 213. SAMEA Antivenom Sales Price by Application (2027-2032) & (USD/Vial) Table 214. SAMEA Antivenom Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 215. SAMEA Antivenom Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 216. SAMEA Antivenom Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 217. SAMEA Antivenom Sales by Country (2021 VS 2025 VS 2032) & (K Vials) Table 218. SAMEA Antivenom Sales by Country (2021-2026) & (K Vials) Table 219. SAMEA Antivenom Sales by Country (2027-2032) & (K Vials) Table 220. SAMEA Antivenom Sales Price by Country (2021-2026) & (USD/Vial) Table 221. SAMEA Antivenom Sales Price by Country (2027-2032) & (USD/Vial) Table 222. Brazil Antivenom Revenue (2021-2032) & (US$ Million) Table 223. Argentina Antivenom Revenue (2021-2032) & (US$ Million) Table 224. Chile Antivenom Revenue (2021-2032) & (US$ Million) Table 225. Colombia Antivenom Revenue (2021-2032) & (US$ Million) Table 226. Peru Antivenom Revenue (2021-2032) & (US$ Million) Table 227. Saudi Arabia Antivenom Revenue (2021-2032) & (US$ Million) Table 228. Israel Antivenom Revenue (2021-2032) & (US$ Million) Table 229. UAE Antivenom Revenue (2021-2032) & (US$ Million) Table 230. Turkey Antivenom Revenue (2021-2032) & (US$ Million) Table 231. Iran Antivenom Revenue (2021-2032) & (US$ Million) Table 232. Egypt Antivenom Revenue (2021-2032) & (US$ Million) Table 233. Key Raw Materials Table 234. Raw Materials Key Suppliers Table 235. Antivenom Distributors List Table 236. Antivenom Customers List Table 237. Research Programs/Design for This Report Table 238. Authors List of This Report Table 239. Secondary Sources Table 240. Primary Sources List of Figures Figure 1. Antivenom Image Figure 2. Global Antivenom Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antivenom Market Size Share 2021 VS 2025 VS 2032 Figure 4. Polyvalent antivenom Image Figure 5. Monovalent antivenom Image Figure 6. Global Antivenom Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Antivenom Market Size Share 2021 VS 2025 VS 2032 Figure 8. Non-profit Institutions Image Figure 9. Hospitals and Clinic Image Figure 10. Global Antivenom Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Antivenom Revenue (2021-2032) & (US$ Million) Figure 12. Global Antivenom Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Antivenom Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Antivenom Revenue Market Share by Region (2021-2032) Figure 15. Global Antivenom Sales (2021-2032) & (K Vials) Figure 16. Global Antivenom Sales by Region: 2021 VS 2025 VS 2032 (K Vials) Figure 17. Global Antivenom Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Antivenom Sales YoY (2021-2032) & (K Vials) Figure 19. Europe Antivenom Sales YoY (2021-2032) & (K Vials) Figure 20. China Antivenom Sales YoY (2021-2032) & (K Vials) Figure 21. Asia (Excluding China) Antivenom Sales YoY (2021-2032) & (K Vials) Figure 22. South America, Middle East and Africa Antivenom Sales YoY (2021-2032) & (K Vials) Figure 23. Global Antivenom Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Antivenom Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Antivenom Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Antivenom Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Antivenom Revenue Market Share by Type (2021-2032) Figure 29. Global Antivenom Sales by Type (2021 VS 2025 VS 2032) & (K Vials) Figure 30. Global Antivenom Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Antivenom Sales Market Share by Type (2021-2032) Figure 32. Global Antivenom Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Antivenom Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Antivenom Revenue Market Share by Application (2021-2032) Figure 35. Global Antivenom Sales by Application (2021 VS 2025 VS 2032) & (K Vials) Figure 36. Global Antivenom Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Antivenom Sales Market Share by Application (2021-2032) Figure 38. North America Antivenom Revenue Share by Type (2021-2032) Figure 39. North America Antivenom Sales Share by Type (2021-2032) Figure 40. North America Antivenom Revenue Share by Application (2021-2032) Figure 41. North America Antivenom Sales Share by Application (2021-2032) Figure 42. North America Antivenom Revenue Share by Country (2021-2032) Figure 43. North America Antivenom Sales Share by Country (2021-2032) Figure 44. Europe Antivenom Revenue Share by Type (2021-2032) Figure 45. Europe Antivenom Sales Share by Type (2021-2032) Figure 46. Europe Antivenom Revenue Share by Application (2021-2032) Figure 47. Europe Antivenom Sales Share by Application (2021-2032) Figure 48. Europe Antivenom Revenue Share by Country (2021-2032) Figure 49. Europe Antivenom Sales Share by Country (2021-2032) Figure 50. China Antivenom Revenue Share by Type (2021-2032) Figure 51. China Antivenom Sales Share by Type (2021-2032) Figure 52. China Antivenom Revenue Share by Application (2021-2032) Figure 53. China Antivenom Sales Share by Application (2021-2032) Figure 54. Asia Antivenom Revenue Share by Type (2021-2032) Figure 55. Asia Antivenom Sales Share by Type (2021-2032) Figure 56. Asia Antivenom Revenue Share by Application (2021-2032) Figure 57. Asia Antivenom Sales Share by Application (2021-2032) Figure 58. Asia Antivenom Revenue Share by Country (2021-2032) Figure 59. Asia Antivenom Sales Share by Country (2021-2032) Figure 60. SAMEA Antivenom Revenue Share by Type (2021-2032) Figure 61. SAMEA Antivenom Sales Share by Type (2021-2032) Figure 62. SAMEA Antivenom Revenue Share by Application (2021-2032) Figure 63. SAMEA Antivenom Sales Share by Application (2021-2032) Figure 64. SAMEA Antivenom Revenue Share by Country (2021-2032) Figure 65. SAMEA Antivenom Sales Share by Country (2021-2032) Figure 66. Antivenom Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Antivenom Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Polyvalent antivenom
  • Monovalent antivenom
Applications
  • Non-profit Institutions
  • Hospitals and Clinic
Companies covered
  • CSL
  • Merck
  • BTG
  • Pfizer
  • Haffkine Bio-Pharmaceutical
  • Rare Disease Therapeutics
  • Flynn Pharma
  • Vins Bioproducts
  • Bharat Serums and Vaccines
  • Serum Biotech
  • MicroPharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Antivenom Market by Type
  3. 1.2.1 Global Antivenom Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Polyvalent antivenom
  5. 1.2.3 Monovalent antivenom
  6. 1.3 Antivenom Market by Application
  7. 1.3.1 Global Antivenom Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Non-profit Institutions
  9. 1.3.3 Hospitals and Clinic
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Antivenom Market Dynamics
  1. 2.1 Antivenom Industry Trends
  2. 2.2 Antivenom Industry Drivers
  3. 2.3 Antivenom Industry Opportunities and Challenges
  4. 2.4 Antivenom Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Antivenom Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Antivenom Revenue by Region
  3. 3.2.1 Global Antivenom Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Antivenom Revenue by Region (2021-2026)
  5. 3.2.3 Global Antivenom Revenue by Region (2027-2032)
  6. 3.2.4 Global Antivenom Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Antivenom Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Antivenom Sales by Region
  9. 3.4.1 Global Antivenom Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Antivenom Sales by Region (2021-2026)
  11. 3.4.3 Global Antivenom Sales by Region (2027-2032)
  12. 3.4.4 Global Antivenom Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Antivenom Revenue by Manufacturers
  2. 4.1.1 Global Antivenom Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Antivenom Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Antivenom Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Antivenom Sales by Manufacturers
  6. 4.2.1 Global Antivenom Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Antivenom Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Antivenom Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Antivenom Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Antivenom Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Antivenom Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Antivenom Manufacturers, Product Type & Application
  13. 4.7 Global Antivenom Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Antivenom Market CR5 and HHI
  16. 4.8.2 2025 Antivenom Tier 1, Tier 2, and Tier 3
5 Antivenom Market by Type
  1. 5.1 Global Antivenom Revenue by Type
  2. 5.1.1 Global Antivenom Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Antivenom Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Antivenom Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Antivenom Sales by Type
  6. 5.2.1 Global Antivenom Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Antivenom Sales by Type (2021-2032) & (K Vials)
  8. 5.2.3 Global Antivenom Sales Market Share by Type (2021-2032)
  9. 5.3 Global Antivenom Price by Type
6 Antivenom Market by Application
  1. 6.1 Global Antivenom Revenue by Application
  2. 6.1.1 Global Antivenom Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Antivenom Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Antivenom Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Antivenom Sales by Application
  6. 6.2.1 Global Antivenom Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Antivenom Sales by Application (2021-2032) & (K Vials)
  8. 6.2.3 Global Antivenom Sales Market Share by Application (2021-2032)
  9. 6.3 Global Antivenom Price by Application
7 Company Profiles
  1. 7.1 CSL
  2. 7.1.1 CSL Company Information
  3. 7.1.2 CSL Business Overview
  4. 7.1.3 CSL Antivenom Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 CSL Antivenom Product Portfolio
  6. 7.1.5 CSL Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Antivenom Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Antivenom Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 BTG
  14. 7.3.1 BTG Company Information
  15. 7.3.2 BTG Business Overview
  16. 7.3.3 BTG Antivenom Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 BTG Antivenom Product Portfolio
  18. 7.3.5 BTG Recent Developments
  19. 7.4 Pfizer
  20. 7.4.1 Pfizer Company Information
  21. 7.4.2 Pfizer Business Overview
  22. 7.4.3 Pfizer Antivenom Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pfizer Antivenom Product Portfolio
  24. 7.4.5 Pfizer Recent Developments
  25. 7.5 Haffkine Bio-Pharmaceutical
  26. 7.5.1 Haffkine Bio-Pharmaceutical Company Information
  27. 7.5.2 Haffkine Bio-Pharmaceutical Business Overview
  28. 7.5.3 Haffkine Bio-Pharmaceutical Antivenom Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Haffkine Bio-Pharmaceutical Antivenom Product Portfolio
  30. 7.5.5 Haffkine Bio-Pharmaceutical Recent Developments
  31. 7.6 Rare Disease Therapeutics
  32. 7.6.1 Rare Disease Therapeutics Company Information
  33. 7.6.2 Rare Disease Therapeutics Business Overview
  34. 7.6.3 Rare Disease Therapeutics Antivenom Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Rare Disease Therapeutics Antivenom Product Portfolio
  36. 7.6.5 Rare Disease Therapeutics Recent Developments
  37. 7.7 Flynn Pharma
  38. 7.7.1 Flynn Pharma Company Information
  39. 7.7.2 Flynn Pharma Business Overview
  40. 7.7.3 Flynn Pharma Antivenom Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Flynn Pharma Antivenom Product Portfolio
  42. 7.7.5 Flynn Pharma Recent Developments
  43. 7.8 Vins Bioproducts
  44. 7.8.1 Vins Bioproducts Company Information
  45. 7.8.2 Vins Bioproducts Business Overview
  46. 7.8.3 Vins Bioproducts Antivenom Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Vins Bioproducts Antivenom Product Portfolio
  48. 7.8.5 Vins Bioproducts Recent Developments
  49. 7.9 Bharat Serums and Vaccines
  50. 7.9.1 Bharat Serums and Vaccines Company Information
  51. 7.9.2 Bharat Serums and Vaccines Business Overview
  52. 7.9.3 Bharat Serums and Vaccines Antivenom Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Bharat Serums and Vaccines Antivenom Product Portfolio
  54. 7.9.5 Bharat Serums and Vaccines Recent Developments
  55. 7.10 Serum Biotech
  56. 7.10.1 Serum Biotech Company Information
  57. 7.10.2 Serum Biotech Business Overview
  58. 7.10.3 Serum Biotech Antivenom Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Serum Biotech Antivenom Product Portfolio
  60. 7.10.5 Serum Biotech Recent Developments
  61. 7.11 MicroPharm
  62. 7.11.1 MicroPharm Company Information
  63. 7.11.2 MicroPharm Business Overview
  64. 7.11.3 MicroPharm Antivenom Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 MicroPharm Antivenom Product Portfolio
  66. 7.11.5 MicroPharm Recent Developments
8 North America
  1. 8.1 North America Antivenom Market Size by Type
  2. 8.1.1 North America Antivenom Revenue by Type (2021-2032)
  3. 8.1.2 North America Antivenom Sales by Type (2021-2032)
  4. 8.1.3 North America Antivenom Price by Type (2021-2032)
  5. 8.2 North America Antivenom Market Size by Application
  6. 8.2.1 North America Antivenom Revenue by Application (2021-2032)
  7. 8.2.2 North America Antivenom Sales by Application (2021-2032)
  8. 8.2.3 North America Antivenom Price by Application (2021-2032)
  9. 8.3 North America Antivenom Market Size by Country
  10. 8.3.1 North America Antivenom Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Antivenom Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Antivenom Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Antivenom Market Size by Type
  2. 9.1.1 Europe Antivenom Revenue by Type (2021-2032)
  3. 9.1.2 Europe Antivenom Sales by Type (2021-2032)
  4. 9.1.3 Europe Antivenom Price by Type (2021-2032)
  5. 9.2 Europe Antivenom Market Size by Application
  6. 9.2.1 Europe Antivenom Revenue by Application (2021-2032)
  7. 9.2.2 Europe Antivenom Sales by Application (2021-2032)
  8. 9.2.3 Europe Antivenom Price by Application (2021-2032)
  9. 9.3 Europe Antivenom Market Size by Country
  10. 9.3.1 Europe Antivenom Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Antivenom Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Antivenom Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Antivenom Market Size by Type
  2. 10.1.1 China Antivenom Revenue by Type (2021-2032)
  3. 10.1.2 China Antivenom Sales by Type (2021-2032)
  4. 10.1.3 China Antivenom Price by Type (2021-2032)
  5. 10.2 China Antivenom Market Size by Application
  6. 10.2.1 China Antivenom Revenue by Application (2021-2032)
  7. 10.2.2 China Antivenom Sales by Application (2021-2032)
  8. 10.2.3 China Antivenom Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Antivenom Market Size by Type
  2. 11.1.1 Asia Antivenom Revenue by Type (2021-2032)
  3. 11.1.2 Asia Antivenom Sales by Type (2021-2032)
  4. 11.1.3 Asia Antivenom Price by Type (2021-2032)
  5. 11.2 Asia Antivenom Market Size by Application
  6. 11.2.1 Asia Antivenom Revenue by Application (2021-2032)
  7. 11.2.2 Asia Antivenom Sales by Application (2021-2032)
  8. 11.2.3 Asia Antivenom Price by Application (2021-2032)
  9. 11.3 Asia Antivenom Market Size by Country
  10. 11.3.1 Asia Antivenom Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Antivenom Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Antivenom Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Antivenom Market Size by Type
  2. 12.1.1 SAMEA Antivenom Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Antivenom Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Antivenom Price by Type (2021-2032)
  5. 12.2 SAMEA Antivenom Market Size by Application
  6. 12.2.1 SAMEA Antivenom Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Antivenom Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Antivenom Price by Application (2021-2032)
  9. 12.3 SAMEA Antivenom Market Size by Country
  10. 12.3.1 SAMEA Antivenom Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Antivenom Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Antivenom Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Antivenom Value Chain Analysis
  2. 13.1.1 Antivenom Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Antivenom Production Mode & Process
  6. 13.2 Antivenom Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Antivenom Distributors
  9. 13.2.3 Antivenom Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst